Candriam S.C.A. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,615,000
-62.2%
1,429,6300.0%0.01%
-55.2%
Q1 2022$4,274,000
-27.4%
1,429,630
-35.7%
0.03%
-23.7%
Q4 2021$5,887,000
-27.0%
2,221,6960.0%0.04%
-30.9%
Q3 2021$8,064,000
-16.4%
2,221,6960.0%0.06%
-16.7%
Q2 2021$9,642,000
+1334.8%
2,221,696
+693.5%
0.07%
+1000.0%
Q3 2020$672,000
-81.1%
280,000
-85.6%
0.01%
-84.2%
Q2 2020$3,556,000
-30.4%
1,943,000
-20.5%
0.04%
-33.3%
Q1 2020$5,111,000
-2.2%
2,443,0000.0%0.06%
+1.8%
Q4 2019$5,228,000
+12.8%
2,443,000
-1.4%
0.06%
-8.2%
Q3 2019$4,634,000
-67.5%
2,478,000
-0.3%
0.06%
-65.7%
Q2 2019$14,275,000
+124.1%
2,485,450
+0.3%
0.18%
+119.8%
Q1 2019$6,369,000
+11.8%
2,478,0000.0%0.08%
-8.0%
Q4 2018$5,699,000
-21.7%
2,478,000
+9.3%
0.09%
-9.3%
Q3 2018$7,280,000
+63.9%
2,268,000
+44.5%
0.10%
+38.6%
Q2 2018$4,443,000
-16.6%
1,570,000
+4.3%
0.07%
-23.1%
Q1 2018$5,328,000
+12.5%
1,505,000
+23.4%
0.09%
+11.0%
Q4 2017$4,734,000
+47.3%
1,220,000
-3.6%
0.08%
+46.4%
Q3 2017$3,213,000
-0.3%
1,265,000
+7.2%
0.06%
-8.2%
Q2 2017$3,222,000
-10.3%
1,180,000
+8.8%
0.06%
-12.9%
Q1 2017$3,592,000
+145.4%
1,085,000
+76.4%
0.07%
+105.9%
Q4 2016$1,464,000
-45.0%
615,000
-15.2%
0.03%
-46.9%
Q3 2016$2,661,000725,0000.06%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders